ASCEND
Live / Applied — Final refusal mailed (as of 15 Dec 2025)
What this means for you
Not registered yet, but its 04 Jun 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90755378
- Mark type
- Design + words
- Filed
- 04 Jun 2021
- Attorney of record
- Howard Shipley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, mycophenolate mofetil capsules, cephalexin capsules, metformin hydrochloride tablets, ibuprofen tablets, amlodipine besylate tablets, benzonatate capsules, temazepam capsules, quetiapine fumarate tablets
Owner
- Ascend Laboratories, LLC, Parsippany, NJ, US
Prosecution history
- 13 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 15 Dec 2025 — FINAL REFUSAL E-MAILED
- 15 Dec 2025 — FINAL REFUSAL WRITTEN
- 12 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 12 Mar 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 12 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2023 — NON-FINAL ACTION E-MAILED
- 12 Dec 2023 — NON-FINAL ACTION WRITTEN
- 07 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE